These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 3011047

  • 1. Age and the pharmacodynamics of angiotensin converting enzyme inhibitors enalapril and enalaprilat.
    Ajayi AA, Hockings N, Reid JL.
    Br J Clin Pharmacol; 1986 Apr; 21(4):349-57. PubMed ID: 3011047
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ, Lees KR, Reid JL.
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Unrelated responses of brachial artery hemodynamics and renin-angiotensin system to acute converting enzyme inhibition by enalaprilat in essential hypertension.
    Levenson J, Chau NP, Billaud E, Simon A.
    Am J Cardiol; 1988 May 01; 61(13):1056-60. PubMed ID: 2834938
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of enalapril, a new converting enzyme inhibitor, in hypertension.
    Ferguson RK, Vlasses PH, Swanson BN, Mojaverian P, Hichens M, Irvin JD, Huber PB.
    Clin Pharmacol Ther; 1982 Jul 01; 32(1):48-53. PubMed ID: 6282527
    [Abstract] [Full Text] [Related]

  • 12. Effect of cimetidine on the pharmacokinetics and pharmacodynamics of enalapril in normal volunteers.
    Ishizaki T, Baba T, Murabayashi S, Kubota K, Hara K, Kurimoto F.
    J Cardiovasc Pharmacol; 1988 Jul 01; 12(5):512-9. PubMed ID: 2468049
    [Abstract] [Full Text] [Related]

  • 13. Effect of dietary sodium on angiotensin-converting enzyme (ACE) inhibition and the acute hypotensive effect of enalapril (MK-421) in essential hypertension.
    Jackson B, Cubela R, Johnston CI.
    J Hypertens; 1984 Aug 01; 2(4):371-7. PubMed ID: 6099390
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Acute and chronic effects of a novel dihydrobenzofuran analogue and enalapril on blood pressure and plasma and tissue angiotensin converting enzyme activity in the sodium deficient normotensive rat.
    Longman SD, Howlett DR.
    Arzneimittelforschung; 1988 May 01; 38(5):678-82. PubMed ID: 2843192
    [Abstract] [Full Text] [Related]

  • 16. Blood pressure response to enalaprilic acid in essential hypertension: dose-response and effect of pre-treatment with furosemide.
    Navis GJ, de Jong PE, Donker AJ, van der Hem GK, de Zeeuw D.
    Eur J Clin Pharmacol; 1985 May 01; 29(1):9-15. PubMed ID: 2996907
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the oral angiotensin II receptor antagonist UP 269-6 or enalapril 20 mg on blood pressure and neurohormonal effects in salt-deplete man.
    McIntyre M, MacFadyen RJ, Meredith PA, Menard J, Brunner HR, Insuasty J, Reid JL.
    J Cardiovasc Pharmacol; 1995 Jun 01; 25(6):994-1000. PubMed ID: 7564347
    [Abstract] [Full Text] [Related]

  • 18. Consequences of angiotensin-converting enzyme inhibitor overdose.
    Varughese A, Taylor AA, Nelson EB.
    Am J Hypertens; 1989 May 01; 2(5 Pt 1):355-7. PubMed ID: 2541742
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.